Jarra W, Brown K N
Parasite Immunol. 1985 Nov;7(6):595-606. doi: 10.1111/j.1365-3024.1985.tb00103.x.
CBA/Ca mice were immunized by infection with cloned lines of Plasmodium berghei (isolates ANKA, KSP-11). Plasmodium chabaudi chabaudi (AS, CB) or Plasmodium chabaudi adami (DS) and then challenged with either homologous or heterologous parasites. Protective responses were assessed in immune mice relative to the controls by their ability to (i) extend the time taken for the mean parasitaemia to reach a predetermined level (1% or 0.1%) (ii) reduce peak parasitaemia (iii) resolve the parasitaemia sooner and/or (iv) control or eliminate recrudescences. At both the inter- and intra-species level, immunity appeared largely specific for the cloned line inducing it. At the interspecies level marginally effective cross-immunity was sometimes evident, thus P. berghei KSP-11 immune mice displayed some immunity against P.c. chabaudi AS, although immunity to this parasite was relatively ineffective against P. berghei ANKA or KSP-11. Cross-immunity was more apparent between the subspecies P.c. adami and P.c. chabaudi and between cloned lines of the latter parasite derived from the AS and CB isolates. These data reflect considerable inter- and intra-species structural and immunogenic differences in certain antigens of parasitized erythrocytes and merozoites, which have been identified in a number of murine malarias and associated with protective immunity. Similar differences recently identified in the equivalent antigens of the human parasite P. falciparum may therefore have important implications for protective immunity in man.
CBA/Ca小鼠通过感染伯氏疟原虫(分离株ANKA、KSP-11)、查巴迪疟原虫(AS、CB)或亚当疟原虫(DS)的克隆系进行免疫,然后用同源或异源寄生虫进行攻击。通过以下能力评估免疫小鼠相对于对照的保护性反应:(i)延长平均寄生虫血症达到预定水平(1%或0.1%)所需的时间;(ii)降低寄生虫血症峰值;(iii)更快地消除寄生虫血症;和/或(iv)控制或消除复发。在种间和种内水平上,免疫在很大程度上似乎对诱导它的克隆系具有特异性。在种间水平上,有时明显存在轻微有效的交叉免疫,因此伯氏疟原虫KSP-11免疫小鼠对查巴迪疟原虫AS表现出一定的免疫力,尽管对该寄生虫的免疫对伯氏疟原虫ANKA或KSP-11相对无效。亚当疟原虫和查巴迪疟原虫亚种之间以及后者寄生虫源自AS和CB分离株的克隆系之间的交叉免疫更为明显。这些数据反映了在许多鼠疟中已鉴定出的、与保护性免疫相关的、寄生红细胞和裂殖子某些抗原在种间和种内存在相当大的结构和免疫原性差异。因此,最近在人类寄生虫恶性疟原虫的等效抗原中发现的类似差异可能对人类的保护性免疫具有重要意义。